Trademark Overview
On Monday, November 18, 2024, a trademark application was filed for NUCLEUS with the United States Patent and Trademark Office. The USPTO has given the NUCLEUS trademark a serial number of 98858452. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, November 18, 2024. This trademark is owned by b.next, Inc.. The NUCLEUS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for use in the field of cellular engineering to produce engineered cells; engineered cells for medical or clinical use; preparations for the cell free production of therapeutic proteins or peptides for medical use; genetically and otherwise modified cells for medical or clinical use